Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study

Research output: Contribution to journalJournal articlepeer-review

View graph of relations

We investigated trends of survival in a population-based cohort study of all 181 adults who received HCT for ALL in Denmark between 2000-2019. Patients had a median (min-max) age of 36 (18-74) years at HCT and were followed for a median of eight years. Overall survival (OS) improved over time with an estimated 2-year OS of 49% (CI 27-66%) in year 2000 versus 77% (CI 59-88%) in year 2019. More patients achieved cure over time (OR for cure per year 1.07, CI 1.00-1.15), while the rate of death in non-cured patients remained stable (HR of excess mortality per year 0.99, CI 0.93-1.06). Relapse decreased over time (HR 0.92 per year, CI 0.87-0.98), whereas non-relapse mortality did not change notably (HR 0.98 per year, CI 0.93-1.04). In conclusion, survival after HCT in adults with ALL has improved over the past two decades, primarily due to more patients achieving cure.

Original languageEnglish
JournalLeukemia and Lymphoma
Issue number2
Pages (from-to)416-425
Number of pages10
Publication statusPublished - Feb 2022

    Research areas

  • acute lymphoblastic leukemia, ALL, allogeneic hematopoietic stem cell transplantation, Allogeneic transplantation, survival

ID: 69934084